BRAIN-ALGGN 2021

Welcome Message by Organising Committee

Having lost BRAIN 2020 due to the on-going coronavirus pandemic, we welcome you to the exciting and rich Virtual Congress of conjoined BRAIN 2021 and the 2nd Asia Pacific Low-Grade Glioma Network Meeting (ALGGN), stronger and better connected.

Not only have we gathered Advanced Therapeutics and Innovative Technologies for Brain Disorders, and Advances in MIS Spine Surgery, but also have made the full spectrum of surgical sciences of Low-Grade Glioma into a feature of this Asia Pacific Conjoint Congress.

To interested neurologists, neurosurgeons, pathologists, clinical and basic scientists, and related health care professionals, please register for this first virtual internet meeting in the 19-year history of the BRAIN Meeting.



Organiser & Supporting Organisations

Organiser
Division of Neurology
Neuropathology
Division of Neurosurgery
The Chinese University of Hong Kong
Supporting Organisations
Hong Kong Neurological Society
Hong Kong Neuro-oncology Society
The Hong Kong Neurosurgical Society
The Hong Kong Neurosurgical Society (Nursing Chapter)
Hong Kong Student Association of Neuroscience
International Academy of Pathology, Hong Kong Division

Congress Secretariat

Division of Neurosurgery, Department of Surgery, The Chinese University of Hong Kong
4/F Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong
Tel: (852) 3505 1316/ 2624/ 1852
Fax: (852) 2637 7974
E-mail: BRAIN-ALGGN2021@surgery.cuhk.edu.hk
Website: www.surgery.cuhk.edu.hk/BRAIN-ALGGN2021

Faculty
(in alphabetical order)


 X
Jubilent AMALENDRAN

Jubilent is a medical student in his penultimate year of studies in King’s College London (KCL). Apart from his clinical interest in neuroradiology, he is also fascinated by the role of neurosciences in understanding the workings of the mind, and the influence of music, meditation and psychedelics on the psyche.

He is also the current President of KCL Neuroscience Society, the aim of which is to unite students who share an interest in Neuroscience. They work closely alongside the Neuroscience department of KCL as well as other Neuroscience societies around London.

Their activities include talks from world class professionals on topics including neuropsychopharmacology, neuroimaging, neurodevelopment and mental illnesses. Despite the limitations due to covid-19, the society has managed to provide a wide range of online talks and a virtual mentorship scheme for neuroscience students.

Jubilent AMALENDRAN
Faculty of Life Sciences and Medicine
King’s College London
London, UK
 X
Chrystalina ANTONIADES

Chrystalina is an Associate Professor in the Nuffield Department of Clinical Neurosciences at the University of Oxford. She is also one of the Official Fellows of the newly founded colleges, Reuben College. Upon finishing her training and PhD at the University of Cambridge, she moved to Oxford to take up a position in Clinical Neurology. There she established her own research group, the NeuroMetrolgy Lab.

Chrystalina's research interest lies primarily in Parkinson's disease. By adopting a variety of quantitative experimental techniques, her team can measure subtle abnormalities of the speed and coordination in various movements such as saccades and motor control.

Her interest in the neurobiological relationship between visual perception and art had led to the development of the Art and Neuroscience Project for the Medical Sciences Division. Many national and international awards awarded Chrystalina's passion and advocacy for public engagement. In 2019 and 2020, she was awarded the Public Engagement with Research Seed fund grant for the project 'Picturing Parkinson's', which aims to bridge the gap between objective research into Parkinson's disease and subjective patient experience of the condition.

Chrystalina ANTONIADES
Nuffield Department of Clinical Neurosciences
Medical Sciences Division
The University of Oxford
Oxford, UK
 X
Junseok BAE

Junseok is a medical graduate of Kyungpook National University, Korea (2001) and board certified in Neurosurgery in 2006. He specialised in endoscopic spine, minimally invasive spine and spinal deformity surgery. He has been given the title of “Best Surgeon” in two consecutive years 2018 and 2019 in Wooridual Spine Hospital in Seoul. He won the “Best Paper Award” in the Society for Minimally Invasive Spine Surgery Annual Forum 2016 in La Vegas. Junseok is current the Director of Wooridual Spine Hospital and Adjunct Professor of Ulsan University Medical School.

Junseok BAE
Department of Neurosurgery
Gyeonggi Provincial Medical Center Pocheon Hospital
Seoul, Korea

 X
Lorenzo BELLO
Professor of Neurosurgery, University of Milan

Lorenzo obtained his medical degree at the University of Turin and Milan (1990) and had been trained in Neurosurgery at Institute of Neurosurgery, University of Milan School of Medicine (1990-1995). He did his overseas training in Neurosurgery and Neuro-oncology at Brigham and Women’s Hospital, Harvard Medical School, Boston in 1997-1998 and 2001-2002 respectively.

Lorenzo has been appointed as Professor of Neurosurgery at Department of Oncology and Hematology-Oncology, and Director of Neurosurgical Training of University of Milan since 2016. He serves as a Research Committee member in the Italian Association for Neuro-oncology, European Association for Neuro-oncology, Italian Society of Neurosurgery and European Association of Neurosurgery (EANS). Lorenzo has made contribution in academic neurosurgical oncology specially in neurophysiological intraoperative imaging technique, as a prolific author and a seasoned teacher with H-index of 38.

Lorenzo BELLO
Department of Oncology and Hematology-Oncology
University of Milan
Milan, Italy
 X
Danny Tat-Ming CHAN

Danny is a medical graduate at The Chinese University of Hong Kong (CUHK). He completed his specialist training in Neurosurgery in 2004 and was awarded the Douglas Miller Gold Medal for distinction in Neurosurgery by The College of Surgeons of Hong Kong and The Royal College of Surgeons, Edinburgh. He received his overseas training for Neuro-Oncology in MD Anderson Cancer Centre under the mentorship of Professor Alfred Wai-Kwan Yung in 2007.

Danny is currently Honorary Clinical Associate Professor and the Head of the Division of Neurosurgery at Department of Surgery, Prince of Wales Hospital (PWH) / CUHK, and Associate Director of the CUHK Otto Wong Brain Tumour Centre. His special interests include Neuro-Oncology, glioma surgery and functional Neurosurgery. In 2009. He and his team established the first one-stop multidisciplinary combined neuro-oncology clinic (CNO) for management of brain tumour patients in Hong Kong. They also introduced awake cortical mapping and fluorescence guided surgery for the management of gliomas. Danny is the founding organiser of the "Hong Kong - Walk around the World for Brain Tumours" Awareness Program (since 2007).

Danny Tat-Ming CHAN
Division of Neurosurgery, Department of Surgery
Prince of Wales Hospital/
The Chinese University of Hong Kong
Hong Kong, China
 X
David Yuen-Chung CHAN

David is currently an Assistant Professor at The Chinese University of Hong Kong. He obtained his medical degree from The University of Hong Kong in 2010 after completing his overseas elective training at the University of Cambridge Addenbrooke’s Hospital, and St Thomas’ Hospital, King’s College London.

During his Neurosurgery Fellowship training, David was awarded the Best Research Award for two consecutive years from the College of Surgeons of Hong Kong (CSHK) in 2016 and 2017. He completed the training in 2018 with a Distinction in his Higher Surgical Training Research Project and was awarded the Best Original Paper Award in 2019 from CSHK.

David is a Council member of the Hong Kong Neurosurgical Society. He is active in both research and teaching. His research interests are endoscopic surgery and minimally invasive surgical techniques in Neurosurgery, head and spine injury.

David Yuen-Chung CHAN
Division of Neurosurgery, Department of Surgery
Prince of Wales Hospital/
The Chinese University of Hong Kong
Hong Kong, China

 X
Edwin Ho-Yin CHAN

Edwin is Professor and Associate Director of Biochemistry Programme at the School of Life Sciences, and Deputy Director of the Bachelor of Science Degree Natural Sciences Programme, Faculty of Science, and Associate Head of Chung Chi College at The Chinese University of Hong Kong (CUHK). Edwin has been involved in a wide spectrum of services at CUHK. Edwin obtained undergraduate training in biochemistry from CUHK, doctoral training in genetics from The University of Cambridge (UK), and postdoctoral training in neuroscience from The University of Pennsylvania (USA).

Throughout the years, Edwin received scholarship and fellowship awards in support of his research training, these include a Croucher Foundation Scholarship, Wellcome Trust International Traveling Research Fellowship, Human Frontier Program Long-Term Research Fellowship, Huntington’s Disease Society of America Postdoctoral Research Fellowship, and Hereditary Disease Foundation John J. Wasmuth Postdoctoral Fellowship. Since 1999, he investigates pathogenic pathways of triplet repeat expansion diseases, including spinocerebellar ataxias, Huntington’s Disease and myotonic dystrophy. He takes a multi-disciplinary approach to identity new disease loci, and to develop therapeutics for triplet repeat expansion diseases.

Edwin’s contribution to the field is recognized. He received various research prizes, including the 2010 CUHK Young Researcher Award, and the Genetics Society of China 13th Ju-Chi Li Animal Genetics Prize in 2011. In 2014, he was awarded a Churchill College Visiting By-Fellowship. Edwin has published over 100 scientific articles. Edwin currently holds 5 US patents. Edwin is Founding Member of The Hong Kong Young Academy of Sciences (YASHK), and serves in the YASHK Executive Committee (2018-2021). He is consultant of the Hong Kong Spinocerebellar Ataxia Association and Chairperson of the Association’s Scientific and Medical Advisory Committee/ He is also advisor of Rare Disease Hong Kong. He also serves as editorial board member of peer-reviewed journals.

Edwin Ho-Yin CHAN
School of Life Sciences
The Chinese University of Hong Kong
Hong Kong, China
 X
Jong-Hee CHANG

Jong-Hee obtained his medical degree and PhD degree in Yonsei University College of Medicine, Korea, in 1991 and 2004 respectively. He received his overseas training in Neurosurgery at Washington University and Cleveland Clinic in 2001-2003 and subsequent Neuro-oncology research in 2010-2011 at The University of Toronto Brain Tumour Research Centre. Jong-Hee has joined Yonsei University College of Medicine as academic neurosurgeon since 2003 and currently a full Professor at Department of Neurosurgery and Director of the Brain Tumour Center of Severance hospital.

Jong-Hee CHANG
Department of Neurosurgery
Yonsei University College of Medicine
Seoul, Korea
 X
Maxwell Chun-Yin CHOI

Maxwell is a third-year MBChB-GPS (Global Physician-Leadership Stream) student at The Chinese University of Hong Kong (CUHK). He graduated from St. Paul’s Co-educational College as the youngest full scorer in the International Baccalaureate Diploma (IBDP) examination at the age of 16 and opted for entry directly into Year 2 to pursue gap year options in academic research related to clinical neuroscience. He has been actively involved in student medical societies, and his roles include Executive Officer in the Department of Clinical Experience at the Hong Kong Student Association of Neuroscience (HKSAN) and Academic Officer of Morningside Medics. Furthermore, he serves as a Faculty Student Ambassador of the Faculty of Medicine, CUHK.

Currently, Maxwell is one of the core investigators in the Enhancing the Use of Telemedicine among Older People In Asia (EUTOPIA) study under supervision by Professor Vincent Mok, and is conducting research on the applications of telemedicine amongst various elderly patient groups, particularly those with behavioral disorders. Moreover, he also does research in neuro-oncology under supervision by Professor H.K. Ng and is now working on molecular characterization of an adult IDH-wildtype glioblastoma cohort with TERTp mutations, aiming to elucidate molecular mechanisms involved in gliomagenesis.

Maxwell Chun-Yin CHOI
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China

 X
Hei-Man CHOW

Hei-Man received her PhD degree in cancer biology at the University of Hong Kong in 2010. She conducted her first postdoctoral training at Cornell University and started a new direction in neuroscience with Prof. Karl Herrup at HKUST since 2013. By 2015, she has been appointed as a Research Assistant Professor in the same laboratory. She receives the Alzheimer's Association Research Fellowship (2017-2021), HKUST-Institute for Advanced Study-Junior Fellowship (2015-current) and serves as a committee member for both the Trainee Advisory Committee (2015-2018) and Trainee Professional Development Awards Selection Committee (2017-2019) of the Society for Neuroscience.

Hei-Man CHOW
School of Life Sciences
The Chinese University of Hong Kong
Hong Kong, China
 X
Hugues DUFFAU
Doctor Honoris Causa
Herbert Olivecrona Medallist, Karolinska Institute
Member of the French National Academy of Medicine
Member of the French National Academy of Surgery
Member of the Royal Academy of Medicine of Belgium
Professor of Surgery, Montpellier University Medical Center

Professor Duffau obtained his master degree in neurosciences (1992) and medical degree (1995) from University of Paris VI (Pierre and Marie Curie University). He received his neurosurgical training at Pitié-Salpêtrière Hospital in Paris (1995-1999) and PhD in neurosciences from University of Paris VI (2000). He was appointed as Professor of Neurosurgery in 2006 and has become Chairman of the Department of Neurosurgery in the Montpellier University Medical Center in France since 2007. Professor Duffau is the Director of the INSERM U1191 Team "Brain Plasticity, Stem cells and Diffuse Low Grade Gliomas" at the National Institute for Health and Medical Research, Institute of Functional Geonomics. He is an expert in the awake cognitive neurosurgery of slow-growing brain tumors, as low-grade gliomas, a routine which he has developed since more than twenty years. His fundamental approach is centered on the concepts of the brain connectomics and neuroplasticity, breaking with the traditional localizationist view of cerebral processing. For his innovative work in neurosurgery and neurosciences, he was awarded Doctor Honoris Causa six times, and he was the youngest recipient of the prestigious Herbert Olivecrona Award from the Karolinska Institute in Stockholm.

Professor Duffau has written four textbooks and over 420 publications in international journals ranging from neurosurgery to fundamental neurosciences, including cognitive sciences and brain plasticity for a total of more than 31,000 citations and with an h-index of 96. He gave more than 560 invited lectures, and was invited as a visiting professor in more than 50 institutions. He is member of Editorial boards of Brain and Language, Neurosurgery and Neuro-oncology and ad-hoc reviewer for around 100 journals (over 950 reviews) including New England Journal of Medicine, Lancet Oncology, Nature Medicine, Nature Reviews Neuroscience, Nature Reviews Neurology; Annals of Neurology, Brain, Cerebral Cortex, Trends in Cognitive Science and Current Biology. He is member of many societies: the French Academy of Medicine, the French Academy of Surgery, the World Academy of Neurological Surgery, the Young Neurosurgeons Award Committee of the World Federation of Neurosurgical Societies, the Scientific Committee of the European Association for Neuro-oncology, to name but a few.

Hugues DUFFAU
Department of Neurosurgery
Gui de Chauliac Hospital, Montpellier University Medical Center
Montpellier, France
 X
Syed Ather ENAM
Professor of Neurosurgery, Aga Khan University Hospital

Professor Enam is a US Board certified Neurosurgeon (2002) and currently the Chairman of Department of Surgery, Aga Kan University Hospital, Pakistan and Programme Director in Neurosurgical Training of Aga Khan University. He received his Surgical Fellowship from Ireland (2000) and Canada (2002). Professor Enam received a number of awards and honours for his work and contribution in USA and Pakistan, including Sitara-e-Imtiaz, one of highest honour and civilian award in Pakistan, Excellance Award in Neurosurgery from Pakistan Society of Neurosurgeons and Outstanding Resident Award from Henry Ford Hospital in USA. His areas of research interests are role of extracellular matrix in tumour invasion, immunotherapy for brain tumours and spinal cord regeneration.

Syed Ather ENAM
Department of Surgery
Aga Khan University Hospital
Karachi, Pakistan

 X
Thomas FOLTYNIE
Professor of Neurology, University College London

Professor Foltynie is Professor of Neurology in the Department of Clinical and Movement Neurosciences, UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is responsible for Movement disorder patients, particularly Parkinson’s disease (PD) patients undergoing advanced treatments such as Deep Brain Stimulation (DBS), Apomorphine and Duodopa. He is chief investigator for a series of trials of Exenatide- a potential neurorestorative treatment for PD, as well as the lead clinician at UCL for trials of alpha synuclein antibosy treatment for PD and Oxford Biomedica/ Axovant’s gene therapy product for PD, and the Transeuro PD cell transplantation programme.

Professor Foltynie has published clinical trials of DBS as a treatment for the cognitive problems associated with advanced PD/DLB, as well as successful results of a trial of Deep Brain Stimulation for the treatment of patients with severe Tourette syndrome. He is interested in the mechanisms of action of DBS as elucidated using functional MRI, and developing ways of providing therapeutic DBS with better benefit to side effect ratios.

He trained in medicine at UCL, qualifying in 1995 then working in Addenbrooke's Hospital, in Cambridge. From 1999 to 2003, he undertook his PhD in Cambridge looking at the heterogeneity of Parkinson's disease, describing differences in cognitive abilities between patients under the influence of various genes including COMT and BDNF, and Tau. He finished his neurology training between Addenbrooke's Hospital, Cambridge and the National Hospital for Neurology and Neurosurgery in London, before taking up his consultant clinical academic position in London in 2008. He was promoted to Professor in 2016.

Thomas FOLTYNIE
Department of Clinical and Movement Neurosciences
University College London
London, UK
 X
Xiang-Dong FU
Professor of Cellular and Molecular Medicine, University of California, San Diego

Dr Fu received his Bachelor of Science degree of Virology from Wuhan University in 1982. He was the first class of the CUSBEA (China-United States Biochemistry Examination and Application) for graduate training. He obtained his Ph.D. degree from Case Western Reserve University in 1988 and competed postdoctoral training at Harvard in 1988. In 1992, he joined the faculty at University of California, San Diego and rose through the rank. He became a Distinguished Professor of Cellular and Molecular Medicine in 2018 at UC, San Diego.

Throughout his academic career, Dr Fu made fours sets of discoveries: (1) He used partially purified spliceosome to raise a large panel of monoclonal antibodies, which led to the discovery of the first non-snRNP splicing factor SC35, a founding of the SR family of splicing regulators, and demonstrated the function of SR proteins in committing pre-mRNA to the splicing pathway. (2) Dr Fu was also responsible for discovering the SRPK family of splicing kinases highly specific for SR proteins and elucidates a dedicated signaling pathway via these kinases to transduce growth factor signaling to the nucleus to regulate alternative splicing. (3) He pioneered studies on cell fate switches mediated by regulatory RNAs and RNA binding proteins and elucidated an RNA program necessary and sufficient to trans-differentiate fibroblasts into functional neurons. (4) Using this new strategy, he directly converted astrocyte into dopaminergic neurons in brain and demonstrated on a Parkinson’s disease mouse model that such strategy is able to reverse the disease phenotype, suggesting a new strategy to treat neurodegenerative diseases.

Dr. Fu’s contributions to biomedical research have been honored by selection as Searle Scholar (1994), Leukemia and Lymphoma Society Scholar (1997), election to AAAS Fellow (2010). and the Ray Wu Society Award (2016).

Xiang-Dong FU
Department of Cellular and Molecular Medicine
University of California, San Diego
La Jolla, USA
 X
Atsushi FUKUI

Atsushi was graduated from Faculty of Medicine, University of Niigata, Japan in 2008. He did his residency in Neurosurgery in Tokyo Metropolitan Police Hospital (2010-2013) and Tokyo Women’s Medical University (TWMU, 2013-2015). He obtained his PhD degree from Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, TWMU. Atsushi has been appointed as Associate Professor since 2019. His research interests are neurosurgical monitoring (in the areas of intraoperative MRI, awake surgery, MSP and SEP), plasticity and neuromodulation.

Atsushi FUKUI
Department of Neurosurgery
Tokyo Women's Medical University
Tokyo, Japan

 X
Ryan P. HAMER

Ryan is a clinical neuroscientist, healthcare executive and medical device enthusiast based in Melbourne, Australia. Having been involved in clinical neurophysiology for a decade, he currently serves as Business Development Manager for a multinational clinical neuroscience and healthcare company, and has been an invited speaker at medical conferences and meetings around Australia, Asia and South Africa. Ryan is also a Clinical Lecturer with the Faculty of Health and Medicine at the University of Sydney, and Unit Coordinator for intraoperative neurophysiology units as part of the Master of Medicine program. In addition to these roles, Ryan was also elected as President of the Intraoperative Neurophysiology Society of Asia-Pacific (INSA) for 2020-2021.

Ryan holds a Bachelor of Science from Swinburne University (Melbourne), a postgraduate degree in Management from Griffith University (Gold Coast), and has undertaken specialist training in the U.S and the U.K. Ryan’s clinical and research interests focus on complex cortico-subcortical mapping for neuroplasticity in glioma patients, having previously introduced contemporary brain mapping techniques throughout Australia and Singapore.

Ryan P. HAMER
Intraoperative Neurophysiology Society of Asia Pacific (INSA) &
Faculty of Medicine and Health, University of Sydney
Melbourne, Australia
 X
Kyi HLAING

Kyi is Clinical Professor at Department of Neurosurgery, North Okkalapa General Hospital, Yangon, Myanmar. He obtained his medical degree in 1994 and Master degree in Medical Science in 1999. He completed his speciality training in Neurosurgery in Yangon General Hospital in 2007.

Kyi has been instrumental in motivating local resources and overseas collaboration in establishing facilities that allow effective neurosurgical investigations and treatments be carried out. This includes the operating room where secure positioning of anaesthetised patients can safely be operated upon, imaging such as CT and MRI, and finally ICU facilities. That allows more complex neurosurgical patients to recover from prolonged anaesthesia and management of traumatic brain injury and brain haemorrhage.

Kyi HLAING
Department of Neurosurgery
North Okkalapa General Hospital
Yangon, Myanmar
 X
Roger Chun-Man HO

Roger completed his medical degree (MBBS) and higher research degree (MD) at The University of Hong Kong and did his basic and advanced Psychiatry training at National University of Singapore. He is a member of the Royal College of Psychiatrists (UK) and a fellow of the Royal College of Physicians (Canada) and Academy of Medicine (Singapore).

He currently works as Associate Professor and Consultant Psychiatrist at the Department of Psychological Medicine, National University of Singapore (NUS). He is the Education Director coordinating teaching, resident training and research for undergraduate and postgraduate students. His recent research studies the effects of antidepressants on the immune system in animals, as well as the application of technology in clinical services and research, including mobile/electronic health and functional near infrared spectroscopy (fNIRS). He is the author or co-author of more than 130 articles published in peer reviewed journals and 6 books published by prestigious publishers including Hodder Arnold (UK) and Taylor and Francis (US).

Roger is extensively involved in medical education. He disseminated psychiatric knowledge through publications of academic books with global influence. The most recent example is the co-authorship and publication of one of the most commonly used postgraduate textbooks by psychiatric trainees, Revision Notes in Psychiatry (3rd edition), since 1998. He has consistently received several teaching awards such as the NUHS Teaching Excellence Award in 2017 and the Annual Outstanding Tutor Award (2011 – 2016).

Roger Chun-Man HO
Department of Psychological Medicine
Yong Loo Lin School of Medicine
National University of Singapore
Singapore

 X
Sanford P.C. HSU

Sanford is a medical graduate of National Yang-Ming University, Taiwan. He subsequently was trained in Neurosurgery and Critical Care Medicine. He is Head of Division of General Neurosurgery, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital. His areas of expertise are neuro-oncology, epilepsy surgery, anaeurysm surgery and neuro-intensive care.

Sanford P.C. HSU
Department of Neurosurgery
Neurological Institute
Taipei Veterans General Hospital
Taipei, Taiwan
 X
Jacque Pak-Kan IP

Jacque obtained his Bachelor of Science in Biochemistry from the University of Sydney with first class honours and university medal, and then received his PhD in Biochemistry at The Hong Kong University of Science and Technology. Jacque received further post-doctoral training at the Picower Institute for Learning and Memory, Massachusetts Institute of Technology (MIT). During his postgraduate study and postdoctoral training, he received a number of awards including the Croucher Studentship, the Sir Edward Youde Memorial fellowship, the International Brain Research Organization (IBRO) Rita Levi-Montalcini Research fellowship, and Human Frontier Science Program (HFSP) Long-Term fellowship. Recently, He has received the Aspirational Neuroscience Prize, RGC early career award, and NARSAD Young Investigator Award. Jacque has devoted his research to investigate the mechanisms of synaptic plasticity, and will continue to expand his research focus on how such mechanistic defects result in autism-related disorders through the use of multidisciplinary approaches. His long-term goal is to apply multidisciplinary cutting-edge neurotechnology to probe brain function in health and disease.

Jacque Pak-Kan IP
School of Biomedical Sciences
The Chinese University of Hong Kong
Hong Kong, China
 X
Nancy Yuk-Yu IP
The Morningside Professor of Life Science, Hong Kong University of Science and Technology

Professor Ip is currently the Vice-President for Research and Development and the Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST). She received her PhD degree in Pharmacology from Harvard Medical School, after which she held the position of Senior Staff Scientist at Regeneron Pharmaceuticals Inc. in New York. Since joining HKUST in 1993, she has served as the Dean of Science, Director of the Biotechnology Research Institute, and Head of the Department of Biochemistry.

Professor Ip is a world-renowned neuroscientist. Her major research interests are in neuronal functions and plasticity, as well as drug discovery for neurodegenerative diseases such as Alzheimer’s disease. She is well-known for her seminal discoveries in the biology of neurotrophic factors, which are proteins that promote the survival, development, and maintenance of neurons in the nervous system. She has also made important contributions towards understanding the molecular mechanisms underlying brain development and synaptic plasticity, and their dysregulation in neurological disorders.

As a highly accomplished researcher, Professor Ip has published 311 papers with over 25,422 SCI citations, and holds 58 patents. She has been elected to the Chinese Academy of Sciences, the World Academy of Sciences, the US National Academy of Sciences, the American Academy of Arts and Sciences, the Hong Kong Academy of Sciences, and the Chinese Academy of Medical Sciences. She currently serves on the editorial boards of PNAS, J Cell Biology, Trends in Neuroscience, National Science Review, and was the Senior Editor of the Journal of Neuroscience.

In recognition of her excellence in science, she has received numerous awards and honours including the National Natural Science Awards, the L’OREAL-UNESCO for Women in Science Award and the 10 Science Stars of China by Nature. Professor Ip is frequently invited to serve with prominent international organizations to steer research directions and policy on a global level. She currently serves as a member of the Leadership Group of the Davos Alzheimer’s Collaborative and the Organizing Committee of the International Common Disease Alliance.

Nancy Yuk-Yu IP
State Key Laboratory of Molecular Neuroscience
Hong Kong University of Science and Technology
Hong Kong, China

 X
Tao JIANG

Professor Jiang obtained his medical degree (1988) and PhD degree (1996) from Harbin Medical University. His 3-year overseas training (2002-4) was conducted in M.D. Anderson, USA. He is now Professor and Vice Chairman of Department of Neurosurgery, Beijing Tiantan Hospital and Duputy Director Beijing Neurosurgical Institute. His clinical and research interests are awake surgery and preservation of function and applied genomics in glioma. He is notably the in-charge person of the Chinese Glioma Genome Network.

Tao JIANG
Department of Neurosurgery
Beijing Tiantan Hospital, Capital Medical University
Beijing, China
 X
Chae-Yong KIM

Chae-Yong obtained his Bachelor (1994), Master (1999) and Doctoral (2004) degrees from Seoul National University College of Medicine. After resident training in Neurosurgery (1995-1999) he was recruited to the Armed Forces Capital Hospital as Military Neurosurgeon (2000-2002). He joined Seoul National University (SNU) Bundang Hospital as academic neurosurgeon in 2004 and has become a Professor since 2016. He is also holding a Professorship at Department of Neurosurgery, Seoul National University (SNU) College of Medicine. Chae-Young is currently the Chief of Neuro-oncology Division of Department of Surgery of SNU Bundang Comprehensive Cancer Hospital and Bundang Clinical Neuro-Science Institute.

Chae-Yong is specialised in brain tumour surgery and neuro-oncology, in particular malignant gliomas. Quality of life of this group of patients is his research interest. Chae-Yong introduced the multidisciplinary approach to the clinic for the management of brain tumours in Korea.

Chae-Yong KIM
Department of Neurosurgery
Seoul National University Bundang Hospital
Seoul National University College of Medicine
Seongnam, Korea
 X
Owen Ho KO

Owen holds a Bachelor of Medical Sciences and Medical degree from The Chinese University of Hong Kong. He pursued his PhD in Neuroscience under the supervision of Professor Thomas Mrsic-Flogel at University College London in the UK and won the runner-up award of the 2014 Eppendorf & Science Prize for Neurobiology based on his PhD works.

Owen serves as a principal investigator at the Gerald Choa Neuroscience Center and the Li Ka Shing Institute of Health Sciences of the Chinese University of Hong Kong. Leading a team with expertise in biology, chemistry and engineering, his research works focus on (i) the principles by which neural circuits mediate sensory perception and behavior, (ii) neurovascular and glial dysfunction in neurodegeneration, and (iii) the development of novel neuroimaging tools.

Owen Ho KO
Division of Neurology
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
Hong Kong, China

 X
Alex Chun-Hay KWAN

Alex was born and raised in Hong Kong. He received a Bachelor of Science degree in Engineering Physics from Simon Fraser University and a PhD in Applied Physics from Cornell University. At Cornell, he developed nonlinear optical microscopes in the laboratory of Watt Webb. For postdoctoral studies, as a Croucher Fellow at the University of California, Berkeley, he worked in the laboratory of Yang Dan, where he studied cortical microcircuits. He joined the Yale School of Medicine faculty in 2013.

Research in the Alex’s lab focuses on the mouse medial frontal cortex. He is interested in how cortical circuits enable flexible decision-making, and how dendritic dysfunctions underlie neuropsychiatric disorders. The expertise of the lab lies in developing and applying optical methods to record and control neural activity in behaving mice.

Alex Chun-Hay KWAN
Division of Molecular Psychiatry
Yale School of Medicine
Yale University
New Haven, USA
 X
Hei-Ming LAI

Hei-Ming is a psychiatrist-neuroscientist in training and is a clinical lecturer in the Department of Psychiatry, The Chinese University of Hong Kong. He has been involved in the development of neuroscientific research tools for six years, with his foundational work published in leading journals as first and corresponding authors. His work has been awarded a Gold Medal in the 46th International Exhibitions of Inventions Geneva and Honourable Mention in Nikon Small World Photomicrography Competition. Although a young researcher, Hei-Ming has already secured millions of dollars for further basic and translational development on his inventions. His current research interests include neuroscientific research tool development, biomarker discovery, neuropsychopharmacology, and neural mechanisms of psychiatric diseases.

Hei-Ming LAI
Department of Psychiatry
The Chinese University of Hong Kong
Hong Kong, China
 X
Joseph Ming-Kuen LAM

Joseph received his medical degree in 1989 from The Chinese University of Hong Kong (CUHK)/ Prince of Wales Hospital (PWH) where he completed his residency training in Neurosurgery. He did his clinical fellowship in the Department of Neurosurgery, University of Cambridge/ Addenbrooke’s Hospital Cambridge in 1995-1996.

Joseph was board-certified as specialist neurosurgeon in 1997 and had been appointed as Consultant Neurosurgeon (1998-2005) and Honorary Associate Professor (since 1998) at the Division of Neurosurgery, Department of Surgery, PWH/ CUHK. He then started his practice in 2015. His main areas of clinical interests are spine surgery and subarachnoid haemorrhage. Joseph is an enthusiast in providing surgical training in spine for both neuro- and orthopaedic surgeons. He has been a Council Member of the Hong Kong Stroke Society since 2001.

Joseph Ming-Kuen LAM
Virtus Medical Group, Ltd
Hong Kong, China

 X
Zachary Yu-Him LAU

Zachary is currently a penultimate medical student of The Chinese University of Hong Kong (CUHK) undertaking the MSc of Research Medicine. Prior to his transfer to the medical program in CUHK, Zachary studied in Biochemistry for two years. Under the supervision of Dr Owen H. Ko, and Dr Hei-Ming Lai, his primary research focus for the MSc lies in the optimisation of techniques in brain tissue imaging, particularly in the area of 3D imaging.

Zachary Yu-Him LAU
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China
 X
Liam Seungjin LEE

Liam is a 5th year medical student from The University of Edinburgh with a strong interest in neurology. As the President of Edinburgh University Neurological Society, he oversees the projects within five domains, namely International Conference, Neuroanatomy, Neuroscience, Neurosurgery, and Public Engagement. He looks forward to integrating online platforms to their projects.

Some widely accoladed projects include Neurotheatre, a theatrical lecture in which audience follows a patient from injury to recovery, witnessing a 'live' performance of brain surgery; and TED-like monthly talks, where experts are invited to share their views on highly debated neuroscience topics such as neurodegeneration and regeneration, mental health, artificial intelligence etc.

Liam Seungjin LEE
The University of Edinburgh Medical School
Edinburgh, UK
 X
Michael Wing-Yan LEE

Michael is a Consultant Neurosurgeon at Pamela Youde Nethersole Eastern Hospital in Hong Kong. Serving as the President of the Hong Kong Neurosurgical Society, he is actively involved in the development of neurosurgery and training of young neurosurgeons in Hong Kong. He is an Honorary Clinical Associate Professor at Department of Surgery, The Chinese University of Hong Kong.

Michael is devoted in promoting neuroscience knowledge in Hong Kong. As the Vice-President of the Hong Kong Brain Foundation, a charitable organisation aimed at promoting brain health and supporting brain related research projects and public education programmes, he goes the extra mile to introduce to the younger generation in the capacity of the coordinator of the Hong Kong Brain Bee Competition the realm of neuroscience. Besides, he is the webmaster and councillor of the Hong Kong Movement Disorder Society and Hong Kong Neuro-Oncology Society. Moreover, he is a trainer and the training centre coordinator of the Advanced Stroke Life Support (ASLS) course in Hong Kong.

Michael Wing-Yan LEE
Department of Neurosurgery
Pamela Youde Nethersole Eastern Hospital
Hong Kong, China

 X
Gerardo Dizon LEGASPI

Dr Legaspi is a mature neurosurgeon based in The University of the Philippines-Philippine General Hospital in Manila. He is specialising in aneurysm and brain tumour, both microsurgical and endoscopic treatment approaches. Dr Legaspi is the Chief Adviser to Philippines Brain Tumour Alliance. He is active in tackling difficult clinical problems in brain tumours, both children and adults.

Gerardo Dizon LEGASPI
Division of Neurosurgery
Department of Neurosciences
The University of the Philippines-Philippine General Hospital
Manila, Philippines
 X
Laura Lok-Wa LEUNG

Laura is currently a final year Global Physician-Leadership Stream (GPS) medical student at The Chinese University of Hong Kong. Prior to her medical studies, she graduated from University College London with a Biomedical Sciences degree with honours. She currently chairs as the Director of Clinical Experience within the Hong Kong Student Association of Neuroscience, an association that focuses on broadening awareness of neuroscience within the wider Hong Kong student community.

During her time at UCL, she discovered her passion for the study of Neuroscience and completed her undergraduate thesis within the field of behavioural neuroscience. Since then, she has narrowed her research interest to neuroimaging and its applications in Neurosurgery. She has completed multiple research projects at the University of Toronto, Harvard Medical School, and the Brigham and Women’s Hospital, published numerous papers and presented at a number of international conferences. Currently, she also serves as an active member of the local research community, focusing on the use of MRI-associated imaging modalities to improve clinical outcomes of Deep Brain Stimulation patients.

Laura Lok-Wa LEUNG
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China
 X
Vincent Chung-Tong MOK
Mok Hing Yiu Professor of Medicine, The Chinese University of Hong Kong (CUHK)

Vincent's research aims to understand mechanisms of dementia and to investigate strategies that may help to prevent dementia and cerebrovascular disease. He is the first in Asia to report the association of cerebral small vessel disease and cognitive impairment, as well as the first in the world to utilize in-vivo amyloid PET imaging in understanding the contribution of amyloid pathology in poststroke dementia. Moreover, he also specializes in Parkinson's disease and was one of the pioneers of developing Deep Brain Stimulation programme in the region.

He received the Higher Education Outstanding Scientific Research Output Award (Science & Technology) in Natural Sciences (1st Class), from the Ministry of Education, People's Republic of China in 2011 for his research in cerebrovascular disease, and the Excellent Research Award, from the Food and Health Bureau of the Hong Kong Special Administrative Region in 2017 for his research in vascular cognitive disorder. He received 7 times Teacher of the Year Award and the Master Teacher Award.

Vincent has authored more than 300 publications in peer-reviewed international journals (with book chapters), with publications at Lancet, JAMA, Lancet Neurology, Nature Reviews Neurology, JAMA Psychiatry, Alzheimer's & Dementia, Annals of Neurology, Neurology, JNNP and Stroke.

Vincent Chung-Tong MOK
Division of Neurology
Department of Medicine and Therapeutics
Prince of Wales Hospital/
The Chinese University of Hong Kong
Hong Kong, China

 X
Yoshihiro MURAGAKI

Yoshihiro is currently Professor at Institute of Advanced Biomedical Engineering and Science, Faculty of Advanced Techno-Surgery, Tokyo Women’s Medical University. He is a 1986 medical graduate of Kobe University, qualified as a Specialist Neurosurgeon in 1992 from Tokyo women’s Medical university. As an enthusiast in technology-driven neurosurgery, he acquired one PhD study in Tokyo Women in 1997, and a second PhD study in Biomedical Science from Waseda University.

His overseas training was way back in 1999-2001 at University of Pennsylvania, working on pathology and laboratory medicine. As a young fellow, he has won a number of prestigious prizes: The Good Design Award (2007), Microsoft Innovation Award (2013), The Japanese Open Innovation Prize (Ministry of Health, Labour and Welfare 2019), just to name a few. He has been a Full Professor since 2011, and his clinical and research focuses are around brain tumours, intraoperative MRI and regulatory sciences.

Yoshihiro MURAGAKI
Institute of Advanced Biomedical Engineering and Science
Faculty of Advanced Techno-Surgery
Tokyo Women’s Medical University
Tokyo, Japan
 X
Vairavan NARAYANAN
Chair Professor, The Chinese University of Hong Kong (CUHK)

Dr Vairavan is an Associate Professor and Consultant Neurosurgeon in University of Malaya (UM). He did his basic medical degree and Master degree in Surgery in the National University of Malaysia (UKM). He started his Neurosurgical training in UM in 2006 and completed his training in Addenbrookes Hospital, Cambridge in 2012. He acquired the Neurosurgical Fellowship from the Intercollegiate Board of Surgery in UK. He spent a further 6 months in 2012 doing an Honorary Fellowship in Epilepsy in University College London. He was recognised as a Malaysian National Specialist Registry (NSR) gazetted consultant Neurosurgeon in 2013.

His clinical interest lies in Neuro Oncology, Epilepsy and Skull Base Surgery. He works closely with the adult and paediatric Neurologists in UM and has built up a successful Epilepsy surgery Unit which screens an average of 50 patients a year, of whom about 20 undergo surgery. With his fellow neurosurgeons and neuro-oncologists, he also runs a dedicated Neuro-oncology Unit which provides the highest standards of care for brain tumour patients.

His research interests include genetic polymorphisms and mutations in primary and secondary brain tumours, traumatic brain injury and its sequeala, innovations in surgery and training. He is also actively involved in academic teaching and supervision of both undergraduate and post graduate Masters and PhD students.

Vairavan NARAYANAN
Division of Neurosurgery, Department of Surgery
Faculty of Medicine, University of Malaya
Kuala Lumpur, Malaysia
 X
Ho-Keung NG

H.K. is Chair Professor at CUHK. His interests are in the molecular pathology of brain tumours, both adult and paediatric. H.K. is both a neuropathologist and general pathologist. He is an Associate Editor of Laboratory Investigation and an Associate Editor of Neuro-Oncology Advances, and is also on the Editorial Boards of Acta Neuropathologica, Brain Pathology, Neuropathology and Applied Neurobiology, Clinical Neuropathology, Pathology and International Journal of Clinical and Experimental Pathology. He was a member of the Consensus Group of the 2007 and 2016 WHO classifications of the brain tumours. And for the upcoming WHO 2020, he is one of the only 10 neuropathologists from around the world selected to make up the Consensus Group.

H.K. was part of the team who received The 2nd Tier Prize of The National Science and Technology Award of China in 2010 and the First Tier Prize of the Science and Technology Award of Shanghai in 2019. He received The International Academy of Pathology Gold Medal twice in 2006 and 2017.

Ho-Keung NG
Department of Anatomical and Cellular Pathology
The Chinese University of Hong Kong
Hong Kong, China

 X
Tak-Lap POON

Dr Poon is a medical graduate of The University of Hong Kong (1998). He completed his neurosurgical training in 2006 and did his overseas training under the mentorship of Mr Willian Harkness (Epilepsy Surgery and Paediatric Neurosurgery) at The Great Ormond Street Hospital for Children NHS Trust and Mr Andrew McEvoy (Epilepsy Surgery, Movement Disorders and Radiosurgery) at The National Hospital for Neurology and Neurosurgery, Queen Square, in 2006. He is currently a Consultant Neurosurgeon of Queen Elizabeth Hospital, Hong Kong.

Tak-Lap POON
Department of Neurosurgery
Queen Elizabeth Hospital
Kowloon
Hong Kong, China
 X
Wai-Sang POON
Emeritus Professor, The Chinese University of Hong Kong (CUHK)

Wai is a Glasgow medical graduate of 1978 and trained in Neurosurgery at Glasgow’s Institute of Neurological Sciences [1983-1986]. He did his research fellowship at Department of Neurosurgery, Massachusetts General Hospital/ Harvard Medical School in 1990-1991. He has joined The Chinese University of Hong Kong (CUHK)/ Prince of Wales Hospital (PWH) as a faculty member in academic neurosurgery since 1986 and became Chief in Neurosurgery [1988-2019] and Chair Professor in 2003. He is currently Emeritus Professor and Clinical Professional Consultant, and Director of the CUHK Otto Wong Brain Tumour Centre.

Wai has a strong interest in clinical and experimental head injury, and more recently cell therapy, cell biology in brain tumours and axonal injury in central nervous system. He has the expertise and motivation to do prospective clinical studies as Principle Investigator in brain injuries. He is author of 450 peer-reviewed publications.

Wai is an active participant of college and society activities locally and internationally. He has been doing medico-legal work since 1992. He is active in undergraduate and postgraduate surgical education, and specialist training in Neurosurgery, as Vice President [Internal Affairs] of The College of Surgeons of Hong Kong (CSHK), Chief Examiner for Neurosurgery and Past Chairman of the Neurosurgery Board [2007-2019] of the CSHK.

Wai-Sang POON
Division of Neurosurgery, Department of Surgery
Prince of Wales Hospital/ The Chinese University of Hong Kong
Hong Kong, China
 X
Stephen John PRICE

Stephen graduated in medicine from Bart’s Medical College in 1994 and did his basic surgical training in the East Midlands. He trained in neurosurgery in Nottingham and Romford before starting the Cambridge training scheme. Stephen was made Clinical Lecturer in 2005 and was appointed Consultant Neurosurgeon with a special interest in managing brain tumours in 2008. He is currently the Network Lead for brain tumours at the Anglian Cancer Network and is Co-Director of the Neuro-Oncology Programme at the Cambridge Cancer Centre. Stephen introduced 5-ALA fluorescence guided surgery to Cambridge to help maximise tumour removal and, with colleagues, regularly teach other surgeons how to use these methods. His practice is largely based around the surgical management of malignant brain tumours (gliomas and metastases).

In 2010 he was awarded a NIHR Clinician Scientist Fellowship. His research interest involves using advanced imaging methods to study the effects of tumours on the normal brain surrounding brain tumours. This work aims to better outline the invasive margin of these tumours and understand the effect of these tumours and treatment on the functioning of the normal brain. In 2016 he developed the Cambridge Brain Tumour Imaging Laboratory - UK's first dedicated brain tumour imaging analysis laboratory. He has been a member of the National Cancer Research Institute (NCRI) Brain Tumour Study Group and the Neuro-oncology Clinical Study Group and was the chair the Imaging and Technology Sub- Group. He is a Bye-Fellow of Queens' College and is the Director of Studies of Clinical Medicine.

Stephen John PRICE
Department of Clinical Neurosciences
University of Cambridge
Cambridge, United Kingdom

 X
Nicholas RAWLINS
Emeritus Professor of Behavioural Neuroscience. The University of Oxford

Professor Rawlins is a behavioural neuroscientist who is currently the Master of Morningside College and Honorary Professor of Psychology in The Chinese University of Hong Kong since December 2018. He completed his BA and DPhil at University College, Oxford and was appointed to a series of posts there before becoming Watts Professor of Psychology in 2005 and Pro-Vice-Chancellor for Development and External Affairs in 2010. On leaving Oxford in 2017 he became Vice-President (Development and International) of the Toulouse School of Economics. He is an Emeritus Professor of Behavioural Neuroscience at the University of Oxford where he also holds Emeritus Fellowships at University College and Wolfson College. He is a Fellow of the Academy of Medical Sciences and a Fellow of the British Psychological Society.

Professor Rawlins specialises in rodent behavioural testing, genes, memory, cognition and emotion, selective brain manipulations and CNS in vivo monitoring. His research extends from neuroanatomical and electrophysiological studies in rodents to cognitive psychology and fMRI paradigms in humans. His work on hippocampal function in rodents was important to define its connections in spatial working memory, object recognition and contextual learning. His hippocampal studies also yielded what became the standard tests for behavioural assessment of hippocampal damage. One important series of studies was his work demonstrating the early, pre-clinical effects of scrapie infection as this offered a method to test therapeutic intervention. His work has not been limited to rodents. He has pioneered novel uses of MRI to differentiate neural substrates underlying the experience of pain and this has been used to investigate the overlapping and separate influences of psychological, physiological and pharmacological interventions.

Nicholas RAWLINS
Morningside College
The Chinese University of Hong Kong
Hong Kong, China
 X
Sith SATHORNSUMETEE

Sith is Associate Professor of Department of Medicine (Neurology) and Assistant Dean for International Relations of the Faculty of Medicine Siriraj Hospital, Mahidol University in Bangkok, Thailand. He also serves as Manager of Siriraj Center of Research Excellence Management (CORE-M) Unit.

Sith received his medical degree from the Faculty of Medicine at Siriraj Hospital, Mahidol University. He completed research training in Neuro-immunology at Mayo Clinic College of Medicine in Rochester, Minnesota, and then neurology residency and neuro-oncology fellowship at Duke University Medical Center in Durham, North Carolina, USA. His clinical expertise includes treatment of patients with brain tumors and neurologic complications of cancer. His research has focused on preclinical and clinical development of novel therapeutic strategies including drug delivery system and precision medicine for brain tumors.

As an active contributor to medical literature, Sith has published more than 80 full-length manuscripts, invited reviews, and international book chapters. In addition, he is also a reviewer for several international journals and granting agencies.

Sith SATHORNSUMETEE
Department of Medicine (Neurology)
Faulty of Medicine Siriraj Hospital
Mahidol University
Bangkok, Thailand
 X
Djaina SATOER

Djaina is currently a Clinical Linguist and Assistant Professor in the Department of Neurosurgery, Erasmus MC University Medical Center in Rotterdam, The Netherlands. She is a linguistics graduate of Utrecht University and a PhD of Erasmus MC University. In 2014-2016, Djaina worked as a coordinator for the Groningen Centre of Expertise for Language and Communication Disorders, a well-known and trusted centre for the development of language tests and their application. Djaina’s expertise concerns language monitoring before, during and after awake brain tumour surgery. Her own primary research interests are in neurolinguistics and cognitive research in patient with acquired brain lesions, in particular gliomas.

Djaina SATOER
Department of Neurosurgery
Erasmus MC University Medical Center
Rotterdam, Netherlands

 X
Peter Zhifeng SHI

Peter is a medical graduate of Shanghai Medical College and completed the residency training in neurosurgery at Huashan under the direct supervision of Academician Zhou Liang-fu. His indepth study of brain tumour pathology research with Professor H.K. Ng of The Chinese University of Hong Kong has started him on a productive path of glioma work. He has carried out Radiomics study in glioma with developing several noninvasive methods predicting molecular biomarkers based on MRI images. He has also worked on advanced biomaterials compatible for neurosurgical implant medical devices. His hard work has resulted in high citation publications in Radiology, Cell Research and Nature Communications. His research is well supported by the Shanghai City Government, National Natural Science Foundation of China (NSFC) and the Chinese 973 Projects.

Peter Zhifeng SHI
Department of Neurosurgery
Huashan Hospital, Fudan University
Shanghai. China
 X
Venus Yu-Hing TANG

Venus is a Clinical Psychologist specialising in neuropsychology and adult psychology. She graduated from the University of Hong Kong (HKU) and thereafter received her Master Degree in Clinical Psychology and Doctor of Philosophy in the Faculty of Medicine from The Chinese University of Hong Kong (CUHK). She was a visiting scholar in the Department of Neurology, David Geffen School of Medicine in the University of California, Los Angeles (UCLA). She is experienced in psychological intervention and mind-body therapy for adult individuals with psychological disorders. Her research interest has been on clinical neuropsychology and her studies have been published in top-ranking journals, e.g. Neurology. She serves as Adjunct Assistant Professor in HKU and CUHK. She is an Associate Fellow of the Hong Kong Psychological Society, the Division of Clinical Psychology and an Associate Member of the American Psychological Association.

Venus Yu-Hing TANG
Department of Clinical Psychology
Prince of Wales Hospital
Shatin
Hong Kong, China
 X
Chottiwat TANSIRISITHIKUL

Chottiwat qualified as a specialist neurosurgeon in 1995 and is currently Assistant Professor in Department of Neurological Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok. He has completed overseas training in Tokyo (1999), Pittsburgh (2003) and Montpellier (2004). He received the Higher Graduate Diploma in Surgical Science from Mahidol University in 2005. His clinical interests are around pituitary and hypothalamus, and glioma surgery.

Chottiwat TANSIRISITHIKUL
Division of Neurological Surgery, Department of Surgery
Faculty of Medicine Siriraj Hospital
Mahidol University
Bangkok, Thailand

 X
Keija TEO

Keija is Assistant Professor and Consultant Neurosurgeon of National University Hospital, National University of Singapore where he obtained his medical degree (2006) and completed his neurosurgical training. He was awarded the Academic Medicine Development Award in 2013 for which he furthered his neurosurgical training for two years in Queen’s Hospital, Romford, London. Subsequently, Keija did his fellowship training in neuro-oncology with Professor Lorenzo Bello at Humanitas Research Hospital in Milan and Professor Hugues Duffau at Gul De Chauliac Hospital in Montpellier. His clinical interests include neuro-oncology, awake craniotomies, functional neurosurgery, neurovascular and skull base surgery, and traumatic head injury.

Keija TEO
Division of Neurosurgery, Department of Surgery
National University Hospital
National University of Singapore
Singapore
 X
Geirmund UNSGÅRD
Professor Emeritus, Norwegian University of Science and Technology (NTNU)

Professor UNSGÅRD has been a Professor at NTNU for 30 years, where he also was Dean of the Medical Faculty for 6 years. He was Chief of Neurosurgical Dept and Head of Neuro-division, St Olav University Hospital for 22 years. He has been using navigated 3D Ultrasound in neurosurgical operations for 23 years. He has published 195 scientific articles in peer reviewed journals and 8 book chapters. The research encompasses cell biology, MR technology and in the last 20 years mostly the use of ultrasound technology to guide and improve neurosurgical operations. He has been entrusted different national and international professional positions. As a politician he was a member of the City Council of Trondheim for 7 years. He left politics about two decades ago when he moved out of the city to a farm nearby with his wife and five children. Here they have a lot of space for their two horses and for receiving visits from family including their 6 grandchildren. In 2009 Professor UNSGÅRD was knighted by the King of Norway (“Knight of St Olavs Order”) for his scientific and professional achievements.

Geirmund UNSGÅRD
Department of Neuromedicine and Movement Science
Norwegian University of Science and Technology
Trondheim, Norway
 X
Kuo-Chen WEI
Professor of Neurosurgery, Chang Gung University

Kuo-chen is a 1985 medical graduate of the Taiwan Chung-Shan Medical College. He did his residency training in neurosurgery in the prestigious Chang Gung Memorial Hospital in Linkuo. He subsequently gets interested in molecular biology of brain tumours and did his research fellowship in Brain Tumour Research Centre of University of California, San Francisco (UCSF) in 1999-2001. He has conducted structured research in biomarkers for glioma. He is currently Professor of Neurosurgery at Chang Gung Memorial Hospital Linkuo Medical Center, continues to work on awake craniotomy, intraoperative brain mapping, focused ultrasound and nanomedicine.

Kuo-Chen WEI
Department of Neurosurgery
Chang Gung Memorial Hospital Linkou Medicine Centre
Chang Gung University
Taoyuan, Taiwan

 X
Desiree Ka-Ka WONG

Desiree is a 5th year medical student of The University of Hong Kong interested in neurosurgery and neuroscience research. She has experience in using MATLAB and 3D Slicer for data analysis and medical image processing.

Desiree has been working with Kwong Wah Hospital Department of Neurosurgery on her research on burr hole placement and trajectory accuracy in ventriculoperitoneal shunts. She was recently invited to present her findings to the Hong Kong Neurosurgical Society ASM in December 2020.

Desiree was also a Student Research Assistant with Dr Hal Blumenfeld at Yale School of Medicine, in a neurology lab specialising in epilepsy and consciousness. Her research involved studying the neural correlates of consciousness in auditory perception, using pupillometry and scalp EEG.

Desiree Ka-Ka WONG
Li Ka Shing Faculty of Medicine
The University of Hong Kong
Hong Kong, China
 X
Queenie Hoi-Wing WONG

Queenie is a 4th year medical student and a candidate for Master of Science in Research Medicine at The Chinese University of Hong Kong. She serves as the Founding President of the Hong Kong Student Association of Neuroscience (HKSAN) which aims to connect and inspire Hong Kong students for the advancement and popularisation of neuroscience. She has been engaged in various local and overseas neuroscience research projects and is now actively involved in neuro-oncology studies, especially in characterising the molecular and clinical profiles of brain tumours.

In HKSAN, she oversees three departments focusing on scientific research, clinical experience, and public health respectively. With the concerted efforts of all Founding Committee members, they have organised their 1st Annual Conference, numerous research and career webinars, and public advocacy events, which cover a wide range of areas including but not limited to neurology, neurosurgery, neuropathology, psychiatry, basic neuroscience, and computational neuroscience.

Queenie Hoi-Wing WONG
Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong, China
 X
Peter Yat-Ming WOO

Peter is a 2004 medical graduate of The University of Hong Kong where he has obtained a Master degree in Medical Science (2010). He received the First Prize of Research of the Year Award from The College of Surgeons of Hong Kong and the Fist Prize of Higher Surgical Trainee Paper Presentation from the Hong Kong Neurosurgery Society during his Neurosurgical Training. He was qualified as Specialist Neurosurgeon in 2013. He subsequently matures in different areas: (1) neuro-oncology, (2) an elected member of the Specialty Board in Neurosurgery, a voice for the young neurosurgeons, and (3) prolific writer in brain tumours and emergency neurosurgery.

Peter Yat-Ming WOO
Department of Neurosurgery
Kwong Wah Hospital
Kowloon
Hong Kong, China

 X
Jinsong WU

Jinsong is currently Professor in Department of Neurosurgery of Huashan Hospital, Fudan University in Shanghai. He is a medical graduate and PhD of the Medical College of Fudan University. He has been doing impactful work on glioma surgery, awake surgery and its intraoperative monitoring. His researches are all clinically relevant, funded by National Key Technology R&D Program of China, the National Natural Science Foundation of China and the Shanghai Science and Technology Committee. Jinsong is also the recipient of many awards, prizes and gold medals, for example from the National Science and Technology Advance Award (second-class), Ministry of Education’s Science & Technology Development/Achievement (first-class) in 2013 and 2014, the 2013 Journal of Neuro-oncology Award granted by the American Association of Neurological Surgeons (AANS). The most impressive event of his recent endeavor has been his successful conquer of a Himalaya summit (>8000 metres) in 2019, the first neurosurgeon ever to have achieved this!

Jinsong WU
Department of Neurosurgery
Hushan Hospital
Shanghai Medical College, Fudan University
Shanghai, China
 X
Tseng-Tsai YEO

Tseng-Tsai is a 1985 medical graduate of the National University of Singapore. He completed his neurosurgical training in Melbourne (FRACS 1994), and functional neurosurgery fellowship in Toronto, Seattle and Grenoble. Having worked in the National Neurological Institute in Singapore, the private sector and now Clinical Associate Professor and Senior Consultant Neurosurgeon and Head of Division of neurosurgery of National University Hospital in Singapore, Tseng-Tsai is in a great position to excel in areas of functional neurosurgery, brain tumour, trauma and virtual reality. The Low-grade Glioma Conjoint Meeting of this year, Tseng-Tsai is the primary driving force behind us.

Tseng-Tsai YEO
Division of Neurosurgery, Department of Surgery
National University Hospital
National University of Singapore
Singapore
 X
Xian-Lun ZHU

Dr Zhu was graduated from the medical school of Jinan University in 1984, He obtained the degree of Master of Philosophy from The Chinese University of Hong Kong in 1992. He received functional and paediatric neurosurgery training in Toronto in 1998. He acquired the qualification of FCSHK, FRCS(Edin) and FHKAM(Surg) in 1998. Currently he is the Consultant Neurosurgeon (part-time) and Honorary Clinical Associate Professor in the Department of Surgery, Prince of Wales Hospital/ The Chinese University of Hong Kong. His main fields of clinical and research interests are functional neurosurgery, paediatric neurosurgery and neurorehabilitation. He is also a member of the World Society for Stereotactic and Functional Neurosurgery (WSSFN), International Society of Pediatric Neurosurgery (ISPN) and Hong Kong Neurosurgical Society, council member of Hong Kong Movement Disorder Society and Hong Kong Epilepsy Society.

Xian-Lun ZHU
Division of Neurosurgery, Department of Surgery
Prince of Wales Hospital/ The Chinese University of Hong Kong
Hong Kong, China

Scientific Programme*

The Virtual Congress Hours:
Hong Kong
14 Jan 2021, Thu
15 Jan 2021, Fri
16 Jan 2021, Sat

(14:00 – 17:30)
(09:00 – 18:35)
(09:00 – 15:15)
Australia Sydney
14 Jan 2021, Thu
15 Jan 2021, Fri
16 Jan 2021, Sat

(17:00 – 20:30)
(12:00 - 21:35)
(12:00 – 18:15)
Central Europe
14 Jan 2021, Thu
15 Jan 2021, Fri
16 Jan 2021, Sat

(07:00 – 10:30)
(02:00 – 11:35)
(02:00 – 08:15)
United States California
13 Jan 2021, Wed
14 Jan 2021, Thu
15 Jan 2021, Fri

(22:00 – 01:30 (+1))
(17:00 – 02:35 (+1))
(17:00 – 23:15)
*All communicated times in the Scientific Programme are Hong Kong Time. Hong Kong is 8 hours ahead of Greenwich Mean Time (i.e. GMT+8 hours).

Programme at a Glance

14 Jan 2021 (Thu) 15 Jan 2021 (Fri) 16 Jan 2021 (Sat)
0900 Welcome Address Session 5A
Low-grade Glioma IV – Safe Maximum Surgery
Session 5B
Circuit & Molecular Pathways in Neurodevelopmental & Psychiatric Diseases
0930 Session 1
Advances in MIS Spine Surgery
1000
1030
1100 Intermission Intermission
1130 Session 2
Low-grade Glioma I
Session 6A
Low-grade Glioma V - Networking Meeting (Round Table Discussion)
Session 6B
Innovative Technologies for Tackling Brain Disorders
1200
1230
1300 Intermission
1330 Intermission Intermission
1400 Satellite Symposium
Hong Kong Student Association of Neuroscience
Session 3A
Low-grade Glioma II
Session 3B
Single-cell Genomics of the Brain
Mr Otto Lien Da Wong Visiting Professorial Lecture in Neuro-Oncology
1430
1500 Closing Remarks
1530 Intermission
1600 Intermission Session 4B
Advanced Therapeutics for Brain Diseases
1630 Session 4A
Low-grade Glioma III
1700
1730
1800  
14 January 2021 (Thu)
Satellite Symposium: Hong Kong Student Association of Neuroscience

14:00 Introduction

Keynote Lecture
Chairpersons :  Bobby HO & Victor MAK
Webinar A
14:10 Introduction
14:13 Proactive Student Engagement in Neuroscience Nicholas RAWLINS
14:53 Q&A and Conclusion  

Panel Discussion I
Chairpersons  :  Matthew LING & Oscar CHOU
Panellists        :  Roger C.M. HO, Owen H. KO, Zachary Y. H. LAU, Desiree K. K. WONG, Laura L.W. LEUNG, Maxwell C.Y. CHOI
Webinar A
15:00 Introduction  
15:05 Challenges and Solutions in Neuroscience Research Among Young Researchers All Panellists
15:30 Panel Discussion & Conclusion  

Panel Discussion II
Chairpersons  :  Jimmy CHU & Mandy YUEN
Panellists        :  Chrystalina ANTONIADES, Michael W.Y. LEE, Jubilent AMALENDRA, Liam S. LEE, Queenie H.W. WONG
Webinar A
16:15 Introduction  
16:20 Global Advocacy of Neuroscience: Experience from Professionals and Students All Panellists
16:45 Panel Discussion & Conclusion  
15 January 2021 (Fri)

09:00 Welcome Address by the Organising Committee

Session 1 : Advances in MIS Spine Surgery
Chairpersons : Wai-Kit MAK & Daniel W.K. NG
Webinar A
09:10 Outcome of MIS TLIF with Expandable Cages David Y.C. CHAN
09:30 Single Position Oblique Lateral Lumbar Interbody Fusion Joseph M.K. LAM
10:00 Pioneer Technology of Endoscopic Spine – Cervical & Thoracic Junseok BAE
10:30 Pioneer Technology of Endoscopic Spine – Lumbar Junseok BAE
11:00 Intermission

Session 2 : Low-grade Glioma I
Chairpersons : Danny T.M. CHAN, Ho-Keung NG & Wai S. POON
Webinar A
11:30 Mixed Reality and Connectomics in Glioma Surgery Tseng-Tsai YEO
11:55 Establishing a Brain mapping Service (Asleep and Awake mapping) in a Neurosurgical Unit in Singapore – Experiences and Lessons Learnt Kejia TEO
12:20 Single-Cell Mapping of Low-grade Glioma Reveals Tumor-Specific Clusters of Tissue-Infiltrated Immune Cells  Tao JIANG
12:50 To Do Genomics or Not Do? Ho-Keung NG
13:20 Intermission

Session 3A : Low-grade Glioma II
Chairpersons : Michael W.Y. LEE & Wai S. POON
Webinar A
14:00 Current Management in Low-grade Glioma Chae-Yong KIM
14:30 Supratotal Excision of Low-grade Glioma Lorenzo BELLO
15:00 Treatment of Lower grade Gliomas: Evidence and Controversies Sith SATHORNSUMETEE
15:30 Science and Surgery of Low-grade Glioma Hugues DUFFAU
16:00 Intermission
Session 3B : Single-cell Genomics of the Brain
Chairperson : Owen H. KO
Webinar B
14:00 Introduction Owen H. KO
14:05 KEYNOTE LECTURE
Transcriptional Reprogramming Promotes Beneficial Microglial Functions in Alzheimer’s Disease

Nancy Y.Y. IP
14:50 Neurovascular and Glial Aging: Transcriptomic Readout and Therapeutic Targeting Owen H. KO
15:20 Intermission

Session 4A : Low-grade Glioma III
Chairpersons : Danny T.M. CHAN & Tom C.Y. CHEUNG
Webinar A
16:15 Imaging for Glioma Stephen J. PRICE
16:45 Ultrasonography in Low-grade Glioma Geirmund Unsgård
17:15 Radiomics on LGG Diagnosis and Clinical Management Peter Z.F. SHI
17:35 Awake Brain Mapping --- Rolandic, Pre-Rolandic, Insular cortex Jinsong WU
18:05 Next Generation Operation Theatre for Glioma Surgery – SCOT Yoshihiro MURAGAKI
Session 4B : Advanced Therapeutics for Brain Diseases
Chairperson :  Vincent C.T. MOK
Webinar B
16:00 Introduction Vincent C.T. MOK
16:05 KEYNOTE LECTURE
GLP-1R Agonists and Other Potential Promising Treatments for Parkinson's Disease in the Clinical Pipeline

Thomas FOLTYNIE
16:50 Neuromodulation for Brain Disorders - Expanding Indications Xian-Lun ZHU
17:20 Peptidylic and small molecule drugs for tackling Hereditary Neurological Disorders Edwin H.Y. CHAN
16 January 2021 (Sat)

Session 5A : Low-grade Glioma V - Safe Maximum Surgery
Chairpersons : Danny T.M. CHAN & Tak-Lap POON
Webinar A
09:00 Hong Kong Surgical Experience in Safe or/and Maximum Resection of Low-grade Glioma Tak-Lap POON
09:15 Technique in Safe and Maximum Surgery - Taiwan Experience Sanford P.C. HSU
09:30 Surgical Technique for Maximal Resection of Low-grade Glioma Chottiwat TANSIRISITHIKUL
09:45 Surgical Techniques and Strategies for Low-grade Glioma in Malaysia Vairavan NARAYANAN
10:00 Surgery of Low-grade Glioma - The Technique and the Experience Jong Hee CHANG
10:15 The Impact of Intraoperative Awake Mapping on Overall Survival and Extent of Resection of Adult Glioma - A Retrospective Propensity Score-matched Analysis: Awake Craniotomy versus Surgery under General Anesthesia for Adult Glioma Atsushi FUKUI
10:30 Optimizing Signals in Cortico-subcortical Mapping and Monitoring Ryan P. HAMER
10:45 Panel Discussion & Conclusion  
11:00 Intermission
Session 5B : Circuit and Molecular Pathways in Neurodevelopmental and Psychiatric Diseases
Chairperson : Jacque P.K. IP
Webinar B
09:00 Introduction Jacque P.K. IP
09:05 KEYNOTE LECTURE
Visualizing the Rapid and Long-lasting Actions of Drugs in the Brain
Alex C. KWAN
09:50 Low-density Lipoprotein Receptor-related Protein 6 Cell Surface Availability Regulates Fuel Metabolism in Astrocytes Hei-Man CHOW
10:20 Dissecting the Roles of Synaptic Plasticity in Neurodevelopmental Disorders Jacque P.K. IP
10:50 Intermission

Session 6A : Low-grade Glioma V - Networking Meeting (Round Table Discussion)
Chairpersons : Danny T.M. CHAN & Peter Y.M. WOO
Webinar A
11:15 Introduction Danny T.M. CHAN
11:20 Management of Low-grade (II/ III) Glioma in Hong Kong – Strength & Deficit Peter Y.M. WOO
11:35 Neuropsychological Evaluations for Adult Brain Tumour Venus Y.H. TANG
11:50 International Adaptation of the Dutch Linguistic Intraoperative Protocol: Experiences and Recommendations Djaina SATOER
12:05 How Glioma is Managed in Myanmar? Kyi HLAING
12:20 Management of Low-grade Glioma in Thailand Sith SATHORNSUMETEE
12:35 Management of Low Grade Glioma in Philippines – The System Gaps and Standard of Care Gerardo D. LEGASPI
12:50 Management of Low Grade Glioma in Pakistan – The System Gaps and Standard of Care S. Ather ENAM
13:05 Standard of Care in the Management of Low-grade Glioma in Taiwan Kuo-Chen WEI
13:20 Panel Discussion & Conclusion  
13:35 Intermission
Session 6B : Innovative Technologies for Tackling Brain Disorders
Chairperson :  Hei-Ming LAI
Webinar B
11:10 Introduction Hei-Ming LAI
11:15 KEYNOTE LECTURE
Making New Neurons to Replenish Lost Ones in Neurodegenerative Disease

Xiang-Dong FU
12:00 Next-generation High-throughput Three-dimensional Histology Pipeline for Neuropathology Hei-Ming LAI
12:30 Intermission

Mr Otto Lien Da Wong Visiting Professorial Lecture in Neuro-oncology
Webinar A
14:00 Recent Advances in Low-grade Glioma Surgery Hugues DUFFAU

15:00 Closing Remarks
Webinar A
Hong Kong Student Association of NeuroscienceX

Founded in 2020, the Hong Kong Student Association of Neuroscience (HKSAN) aims to connect and inspire Hong Kong students for the advancement and popularisation of neuroscience. Composed of the Leadership (3P) and 3 Departments, including Department of Scientific Research (RES), Department of Clinical Experience (CLIN), and Department of Public Health (PUB), we advocate neuroscience through a wide range of activities, including the Annual Conference, research webinars, career talks, doctor-patient interviews, and so on.

www.hksaneuroscience.org

BRAIN-ALGGN 2021 - Evaluation FormX
Poster Presentation

Please sign in to view the poster, to leave your comment(s)/ question(s) to the presenting author(s) and/or to view the responses in this virtual platform.
P1X

EVALUATING EFFECTIVENESS OF MUSIC GROUP IN IMPROVING ATTENTION AND MOOD IN ATTENTION-IMPAIRED PATIENTS IN LOCAL GERIATRIC DAY HOSPITAL SETTING

King Ho CHAN


Please sign in to submit your comment.

P1
EVALUATING EFFECTIVENESS OF MUSIC GROUP IN IMPROVING ATTENTION AND MOOD IN ATTENTION-IMPAIRED PATIENTS IN LOCAL GERIATRIC DAY HOSPITAL SETTING
King Ho CHAN
P2X

PREDICTIVE VALUE OF WADA TEST ON POST-OPERATIVE VERBAL MEMORY IN CHINESE PATIENTS: A CASE STUDY

Samara HUSSAIN


Thanks for the good data! Just would like to comment on the interesting facts that the Wada test is most useful for right handed individuals undergoing right sided surgery - This is because the indication for Wada test would be atypical language dominance. In that case, will there be still some form of benefits conferred by the Wada test in patients with either left handedness or intention to operate on the left side? (Dr. Ho Wan Howan LEUNG)
Thank you for your comment Dr. Leung, hope you are doing well. Based on the findings from this case study, Wada test provided more accurate predictions for right-handed patients undergoing right-sided surgery. However, due to not having left-handed patients in this study, whether there is any benefit could not be investigated. Secondly, since the left hemisphere is traditionally known to be responsible for language, it might retain some language functions even if there is a shift of language functions (for early-onset seizure) to the right hemisphere. This could be another area (apart from bilingualism) to be explored in future research if data allows. (Samara HUSSAIN)

Please sign in to submit your comment.

P2
PREDICTIVE VALUE OF WADA TEST ON POST-OPERATIVE VERBAL MEMORY IN CHINESE PATIENTS: A CASE STUDY
Samara HUSSAIN
P3X

THE EFFECT OF ACUPRESSURE IN THE TREATMENT OF NON-MOTOR SYMPTOMS IN PARKINSON’S DISEASE: A PILOT CLINICAL STUDY

Hong Yi Justin LAI


Please sign in to submit your comment.

P3
THE EFFECT OF ACUPRESSURE IN THE TREATMENT OF NON-MOTOR SYMPTOMS IN PARKINSON’S DISEASE: A PILOT CLINICAL STUDY
Hong Yi Justin LAI

P4X

"REMIND-TO-MOVE” (RTM) APPROACH FOR STROKE PATIENTS: A LITERATURE REVIEW

Ka Chun CHAN


Please sign in to submit your comment.

P4
"REMIND-TO-MOVE” (RTM) APPROACH FOR STROKE PATIENTS: A LITERATURE REVIEW
Ka Chun CHAN
P5X

MOLECULAR LANDSCAPE OF IDH-MUTANT PRIMARY ASTROCYTOMA GRADE IV / GLIOBLASTOMAS

Queenie Hoi Wing WONG


Please sign in to submit your comment.

P5
MOLECULAR LANDSCAPE OF IDH-MUTANT PRIMARY ASTROCYTOMA GRADE IV / GLIOBLASTOMAS
Queenie Hoi Wing WONG
P6X

EXPLORATION OF QUANTITATIVE EEG PARAMETERS IN PEOPLE WITH POST-CONCUSSION SYNDROME AND HEALTHY CONTROLS: A PRELIMINARY STUDY

Yuk Chu CHAN


Please sign in to submit your comment.

P6
EXPLORATION OF QUANTITATIVE EEG PARAMETERS IN PEOPLE WITH POST-CONCUSSION SYNDROME AND HEALTHY CONTROLS: A PRELIMINARY STUDY
Yuk Chu CHAN

P7X

DISRUPTED BRAIN STRUCTURAL NETWORKS IN STROKE PATIENTS WITH BEHAVIOURAL DYSEXECUTIVE SYNDROME

Lisha WANG


Please sign in to submit your comment.

P7
DISRUPTED BRAIN STRUCTURAL NETWORKS IN STROKE PATIENTS WITH BEHAVIOURAL DYSEXECUTIVE SYNDROME
Lisha WANG
P8X

CORTICAL CONNECTIVITY DISRUPTION IN SUBCORTICAL STROKE PATIENTS WITH BEHAVIOURAL DYSEXECUTIVE SYNDROME

Lisha WANG


Please sign in to submit your comment.

P8
CORTICAL CONNECTIVITY DISRUPTION IN SUBCORTICAL STROKE PATIENTS WITH BEHAVIOURAL DYSEXECUTIVE SYNDROME
Lisha WANG
P9X

AN MRI-BASED MACHINE LEARNING METHOD IN THE DIFFERENTIATION OF MILD DEMENTIA WITH LEWY BODIES FROM NORMAL ELDERLY AND ALZHEIMER’S DISEASE

Wan Ting LIU


Please sign in to submit your comment.

P9
AN MRI-BASED MACHINE LEARNING METHOD IN THE DIFFERENTIATION OF MILD DEMENTIA WITH LEWY BODIES FROM NORMAL ELDERLY AND ALZHEIMER’S DISEASE
Wan Ting LIU

P10X

ASSOCIATIONS BETWEEN IMAGING MARKERS OF CEREBRAL SMALL VESSEL DISEASE ADN OUTCOMES AFTER INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Lina ZHENG


Please sign in to submit your comment.

P10
ASSOCIATIONS BETWEEN IMAGING MARKERS OF CEREBRAL SMALL VESSEL DISEASE ADN OUTCOMES AFTER INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Lina ZHENG
P11X

CRANIAL BONE TRANSPORT IMPROVES STROKE OUTCOME IN MCAO RATS

Shanshan BAI


Please sign in to submit your comment.

P11
CRANIAL BONE TRANSPORT IMPROVES STROKE OUTCOME IN MCAO RATS
Shanshan BAI
P12X

ASSOCIATION BETWEEN CEREBRAL SMALL VESSEL DISEASE AND ALZHEIMER’S DISEASE PATHOLOGIES.

Yuan CAI


Please sign in to submit your comment.

P12
ASSOCIATION BETWEEN CEREBRAL SMALL VESSEL DISEASE AND ALZHEIMER’S DISEASE PATHOLOGIES.
Yuan CAI

P13X

THE VALUE OF QUANTITATIVE MRI-BASED BIOMARKERS IN IDENTIFYING MILD ALZHEIMER'S DISEASE

Xiang FAN


Please sign in to submit your comment.

P13
THE VALUE OF QUANTITATIVE MRI-BASED BIOMARKERS IN IDENTIFYING MILD ALZHEIMER'S DISEASE
Xiang FAN

Registration

Welcome to the Virtual Congress of the Conjoint BRAIN-AALGGN Congress. Registration to the Congress is free of charge. All registration should be made through the Online Registration (available until 16 January 2021 15:00 Hong Kong Time).

Delegates will receive a confirmation email containing a special code (PassCODE) from the BRAIN-ALGGN Congress Secretariat in order to sign in and attend the Virtual Meeting on 15-16 January 2021.









Call for Abstracts

Authors are invited to submit abstracts on any clinical, experimental or translational aspects of Nervous System Diseases for consideration by the Committee for e-Poster Presentation.

Authors are required to submit abstracts through Online Abstract Submission. Facsimile or email copy will not be accepted.
Submission Procedure
Abstracts shall be submitted on or before 17 December 2020 Hong Kong Time.

Exhibition & Industry

Sponsorship & Exhibition Opportunities
A Virtual Exhibition will be held jointly with the Conjoint Congress.

This Congress provides a platform for sharing the views and experience from world-leading experts in the fields of Neuro-oncology, Endoscopic Spine, Neurology and Neurosciences. It is indeed a perfect opportunity for the stakeholders in industry to enhance corporate visibility in the fields and update with today’s development among the opinion leaders.

For further details on Sponsorship and Exhibition Opportunities, please contact the Congress Secretariat at BRAIN-ALGGN2021@surgery.cuhk.edu.hk or (852) 3505 1316/ 3505 2624 / 3505 1852.

Virtual Exhibition
(in alphabetical order)

The Organising Committee wishes to thank all the following companies for their generous supports.
Associated Medical Supplies Co. Ltd.X
Room 1201, Fo Tan Industrial Centre
26 Au Pui Wan Street, Fotan
Shatin, New Territories
Hong Kong
(852) 2604 9389
(852) 2694 0866
www.amscl.com
Associated Medical Supplies Co. Ltd.
Baxter Healthcare LimitedX
Suite 2701-03, 27/F, Oxford House
Taikoo Place, 979 King’s Road
Island East, Hong Kong
(852) 2807 8500
(852) 2807 8596
www.baxter.com.hk
Baxter Healthcare Limited
Boehringer Ingelheim (Hong Kong) LimitedX
Suites 1504-9, Great Eagle Centre
23 Harbour Road, Wanchai
Hong Kong
(852) 2596 0033
(852) 2827 0162
www.boehringer-ingelheim.com.hk
Boehringer Ingelheim (Hong Kong) Limited

Brainlab LimitedX
Unit 2502-2503, 25/F, Prosperity Centre
25 Chong Yip Street, Kwun Tong
Kowloon, Hong Kong
(852) 2234 2335
(852) 2413 4321
www.brainlab.com
Brainlab Limited
Eisai (HK) Co. LtdX
Unit D, 18/F, Lee & Man Commercial Centre
169 Electric Road
North Point, Hong Kong
(852) 2516 6128
(852) 2561 5042
www.eisaihk.info
Eisai (HK) Co. Ltd
Elekta LimitedX
12/F, Railway Plaza
39 Chatham Road South
Tsim Sha Tsui, Hong Kong
(852) 9102 1713
(852) 2575 7133
www.elekta.com
Elekta Limited

GlaxoSmithKline LimitedX
23/F, Tower 6, The Gateway
9 Canton Road, Tsim Sha Tsui
Kolwoon, Hong Kong
(852) 3189 8989
(852) 2506 1378
www.gsk.com.hk
GlaxoSmithKline Limited
Greyon Healthcare Co. Ltd.X
Room 14, 3/F, Block A
Wah Tat Industrial Centre
8-10 Wah Sing Street, Kwai Chung
N.T., Hong Kong
(852) 2370 3168
(852) 3741 7189
Greyon Healthcare Co. Ltd.
Johnson & Johnson (Hong Kong) Ltd.X
Room 1001-1009, 10/F, Tower 2
Grand Century Place
193 Prince Edward Road West
MongKok, Kowloon
Hong Kong
(852) 2738 6000
(852) 2736 8697
www.depuysynthes.com
Johnson & Johnson (Hong Kong) Ltd.

KARL STORZ Endoscopy China LtdX
25th Floor, AXA Tower
Landmark East, 100 How Ming Street
Kwun Tong, Kowloon
Hong Kong
(852) 3180 4223
(852) 2865 4114
www.karlstorz.com
KARL STORZ Endoscopy China Ltd
Medtronic Hong Kong Medical LimitedX
Suite 1104-1111, 11/F, Tower 1, The Gateway
Harbour City, Tsim Sha Tsui
Kowloon, Hong Kong
(852) 2919 6550
(852) 2891 6872
www.medtronic.com.hk
Medtronic Hong Kong Medical Limited
Merck Pharmaceutical (HK) LtdX
11/F, Elite Centre
22 Hung To Road
Kwun Tong, Hong Kong
(852) 2170 7700
(852) 2345 2040
www.merckpharma.hk
Merck Pharmaceutical (HK) Ltd

Novartis Pharmaceuticals (HK) LimitedX
7/F, Citi Tower, One Bay East
83 Hoi Bun Road, Kwun Tong
Kowloon, Hong Kong
(852) 2882 5222
www.novartis.com.hk
Novartis Pharmaceuticals (HK) Limited
Nutricia Clinical (Hong Kong) LimitedX
26/F, Lee & Man Commercial Center
169 Electric Road, North Point
(852) 3460 5498
(852) 2191 8162
www.souvenaid.com.hk
Nutricia Clinical (Hong Kong) Limited
Otsuka Pharmaceutical (H.K.) Ltd.X
21/F, East Exchange Tower
38 Leighton Road
Causeway Bay, Hong Kong
(852) 2881 6299
(852) 2577 5206
www.otsuka.hk
Otsuka Pharmaceutical (H.K.) Ltd.

Prism Technologies LimitedX
Unit 604, Yee Kuk Industrial Centre
555 Yee Kuk Street
Cheung Sha Wan, Hong Kong
(852) 2786 3233
(852) 2786 3812
www.prismtech.com.hk
Prism Technologies Limited
S&V Samford Medical Ltd.X
Rm 1606, 16/F, Kodak House II
No. 39 Healthy Street East
North Point, Hong Kong
(852) 2833 9987
(852) 2833 9913
medical.svsamford.com
S&V Samford Medical Ltd.
Stryker China Ltd.X
9th Floor, 12 Taikoo Wan Road
Taikoo Shing, Hong Kong
(852) 3969 1330
(852) 2856 2600
www.stryker.com
Stryker China Ltd.

UCB Pharma (Hong Kong) LtdX
21st Floor, Cityplaza Three
14 Taikoo Wan Road
Taikoo, Hong Kong
(852) 2854 9333
(852) 2854 9111
www.ucb.com
UCB Pharma (Hong Kong) Ltd
Zai Lab (Hong Kong) LimitedX
Room 2301, Island Place Tower
510 King’s Road
North Point, Hong Kong
(852) 3844 8114
(852) 3844 8188
www.zailaboratory.com
Zai Lab (Hong Kong) Limited

General Information

Date
15 – 16 January 2021 (Friday – Saturday)
Time Zone
All communicated times in the Scientific Programme are Hong Kong Time. Hong Kong is 8 hours ahead of Greenwich Mean Time (i.e. GMT + 8 hours).
Webcasts
Scientific sessions will be webcasted via this website.
Official Language
The official language of the Congress is English. There will be no translation provided.
Registration
All registrations should be made through the Online Registration.
Trade Exhibition
A virtual exhibition of medical equipment, books and pharmaceutical brochures will be held during the Congress on 15 – 16 January 2021.
Academic Accreditation (for local participants)
Continuing Medical Education (CME), Continuing Nursing Education (CNE) and Continuing Professional Development (CPD) accreditation will be applied from relevant Hong Kong colleges and associations. Accreditation will be given on condition that the College fellows/ Association members are required to sign in and attend the Virtual Congress on 15 – 16 January 2021 to document the attendance. CME/CNE/CPD points will be given based on the corresponding login/logout time of the live webinar unless otherwise stated. For the approved points awarded by Hong Kong colleges and associations, please click HERE
Disclaimer
Whilst every attempt is made to ensure that all aspects of the Congress as mentioned in this website will take place as scheduled, the Organising Committee reserves the right to make changes should the need arise.

Online Abstracts Submission (All fields are compulsory)×
 X

Danny Tat-Ming CHAN

Danny is a medical graduate at The Chinese University of Hong Kong (CUHK). He completed his specialist training in Neurosurgery in 2004 and was awarded the Douglas Miller Gold Medal for distinction in Neurosurgery by The College of Surgeons of Hong Kong and The Royal College of Surgeons, Edinburgh. He received his overseas training for Neuro-Oncology in MD Anderson Cancer Centre under the mentorship of Professor Alfred Wai-Kwan Yung in 2007.

Danny is currently Honorary Clinical Associate Professor and the Head of the Division of Neurosurgery at Department of Surgery, Prince of Wales Hospital (PWH) / CUHK, and Associate Director of the CUHK Otto Wong Brain Tumour Centre. His special interests include Neuro-Oncology, glioma surgery and functional Neurosurgery. In 2009. He and his team established the first one-stop multidisciplinary combined neuro-oncology clinic (CNO) for management of brain tumour patients in Hong Kong. They also introduced awake cortical mapping and fluorescence guided surgery for the management of gliomas. Danny is the founding organiser of the "Hong Kong - Walk around the World for Brain Tumours" Awareness Program (since 2007).

 X

Wai Sang POON
Emeritus Professor, CUHK

Wai is a Glasgow medical graduate of 1978 and trained in Neurosurgery at Glasgow’s Institute of Neurological Sciences [1983-1986]. He did his research fellowship at Department of Neurosurgery, Massachusetts General Hospital/ Harvard Medical School in 1990-1991. He has joined The Chinese University of Hong Kong (CUHK)/ Prince of Wales Hospital (PWH) as a faculty member in academic neurosurgery since 1986 and became Chief in Neurosurgery [1988-2019] and Chair Professor in 2003. He is currently Emeritus Professor and Clinical Professional Consultant, and Director of the CUHK Otto Wong Brain Tumour Centre.

Wai has a strong interest in clinical and experimental head injury, and more recently cell therapy, cell biology in brain tumours and axonal injury in central nervous system. He has the expertise and motivation to do prospective clinical studies as Principle Investigator in brain injuries. He is author of 450 peer-reviewed publications.

Wai is an active participant of college and society activities locally and internationally. He has been doing medico-legal work since 1992. He is active in undergraduate and postgraduate surgical education, and specialist training in Neurosurgery, as Vice President [Internal Affairs] of The College of Surgeons of Hong Kong (CSHK), Chief Examiner for Neurosurgery and Past Chairman of the Neurosurgery Board [2007-2019] of the CSHK.

 X

Ho-Keung NG
Chair Professor, CUHK

H.K. is Chair Professor at The Chinese of University of Hong Kong (CUHK). His interests are in the molecular pathology of brain tumours, both adult and paediatric. H.K. is both a neuropathologist and general pathologist. He is an Associate Editor of Laboratory Investigation and an Associate Editor of Neuro-Oncology Advances, and is also on the Editorial Boards of Acta Neuropathologica, Brain Pathology, Neuropathology and Applied Neurobiology, Clinical Neuropathology, Pathology and International Journal of Clinical and Experimental Pathology. He was a member of the Consensus Group of the 2007 and 2016 WHO classifications of the brain tumours. And for the upcoming WHO 2020, he is one of the only 10 neuropathologists from around the world selected to make up the Consensus Group.

H.K. was part of the team who received The 2nd Tier Prize of The National Science and Technology Award of China in 2010 and the First Tier Prize of the Science and Technology Award of Shanghai in 2019. He received The International Academy of Pathology Gold Medal twice in 2006 and 2017.

 X

Vincent Chung-Tong MOK
Mok Hing Yiu Professor of Medicine, CUHK

Vincent's research aims to understand mechanisms of dementia and to investigate strategies that may help to prevent dementia and cerebrovascular disease. He is the first in Asia to report the association of cerebral small vessel disease and cognitive impairment, as well as the first in the world to utilize in-vivo amyloid PET imaging in understanding the contribution of amyloid pathology in poststroke dementia. Moreover, he also specializes in Parkinson's disease and was one of the pioneers of developing Deep Brain Stimulation programme in the region.

He received the Higher Education Outstanding Scientific Research Output Award (Science & Technology) in Natural Sciences (1st Class), from the Ministry of Education, People's Republic of China in 2011 for his research in cerebrovascular disease, and the Excellent Research Award, from the Food and Health Bureau of the Hong Kong Special Administrative Region in 2017 for his research in vascular cognitive disorder. He received 7 times Teacher of the Year Award and the Master Teacher Award.

Vincent has authored more than 300 publications in peer-reviewed international journals (with book chapters), with publications at Lancet, JAMA, Lancet Neurology, Nature Reviews Neurology, JAMA Psychiatry, Alzheimer's & Dementia, Annals of Neurology, Neurology, JNNP and Stroke.

 X

Owen Ho KO

Owen holds Bachelor of Medical Sciences (BMedSci, 1st Class) and Bachelor of Medicine and Bachelor of Surgery (MBChB) from CUHK. He pursued PhD in neuroscience under the supervision of Professor Thomas Mrsic-Flogel at University College London in the UK and won the runner-up award of the 2014 Eppendorf & Science Prize for Neurobiology based on his PhD works.

Owen serves as a principal investigator at the Gerald Choa Neuroscience Center and the Li Ka Shing Institute of Health Sciences of the Chinese University of Hong Kong. Leading a team with expertise in biology, chemistry and engineering, his research works focus on (i) the principles by which neural circuits mediate sensory perception and behavior, (ii) neurovascular and glial dysfunction in neurodegeneration, and (iii) the development of novel neuroimaging tools.

Guidelines and Sample for Submission of AbstractsX
Guidelines for Submission of Abstracts
  • Abstracts should be written in English.
  • Each abstract must not exceed 300 words.
  • Abstract title, author name(s) and institution(s) should be clearly stated.
  • ABSTRACT TITLE and AUTHORS’ NAMES should be typed in CAPTITALS. Underline the name of the PRESENTING AUTHOR.
  • Full address(es) of the institution(s) where the scientific work was undertaken should be provided.
  • The content of the abstract should include Background & Objective, Methods, Results and Conclusion(s). You may include up to two Figures and two References for each abstract.
  • The abstract should be in Microsoft Word or PDF format and each file should contain only ONE abstract.
  • The presenting author has to register for the Congress as delegate, otherwise the abstract(s) will not be considered.
  • Abstracts shall be submitted on or before 17 December 2020 Hong Kong Time.

Sample Abstract

Title (Capital & Bold) CLINICALLY IMPORTANT DIFFERENCE OF STROKE-SPECIFIC … …
Authors (Capital) 1WONG GKC, 1LEE A, 2WONG A, … …
Institution 1Division of Neurosurgery, Department of Surgery, 2Division of Neurology, Department of Medicine & Therapeutics, … … The Chinese University of Hong Kong
Country Hong Kong, China
Abstract (no indent for paragraphs) Background & Objective: Health-related quality of … …

Methods: The study recruited SAH patients … …

Results: Over a 2-year period … …

Conclusion: Our study defined the CID for … …

Online Registration ( Required Fields )X
Title : Professor Dr. Mr. Ms.
Family Name :
Given Name :
Department :
Institution :
Region :
Profession :
Email :
Confirm Email :
Academic Accreditation (for local participants) #
College/ Association :
MCHK Reg No.
(Non-specialists)
:
:
# Please provide adequate information for the acquisition of CME/CNE/CPD points.